Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years

By Yahoo! Finance   |   4 days ago
Biogen (NASDAQ:BIIB) sheds US$697m, company earnings and investor returns have been trending downwards for past five years

Long-term investing is recommended, but even long-term holders face losses, like Biogen Inc.'s 56% drop in 5 years. Market fluctuations impact stock prices, not always reflecting a company's true value. Despite recent losses, investors should analyze historical trends before making decisions.

Read More

Did you find this insightful?